FI20020642A0 - Polycyclic compounds as potent alpha2-adrenoceptor antagonists - Google Patents

Polycyclic compounds as potent alpha2-adrenoceptor antagonists

Info

Publication number
FI20020642A0
FI20020642A0 FI20020642A FI20020642A FI20020642A0 FI 20020642 A0 FI20020642 A0 FI 20020642A0 FI 20020642 A FI20020642 A FI 20020642A FI 20020642 A FI20020642 A FI 20020642A FI 20020642 A0 FI20020642 A0 FI 20020642A0
Authority
FI
Finland
Prior art keywords
polycyclic compounds
adrenoceptor antagonists
alpha2
potent
potent alpha2
Prior art date
Application number
FI20020642A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Belle David Din
Reija Jokela
Arto Tolvanen
Antti Haapalinna
Arto Karjalainen
Jukka Sallinen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Priority to FI20020642A priority Critical patent/FI20020642A0/en
Publication of FI20020642A0 publication Critical patent/FI20020642A0/en
Priority to UA20041108959A priority patent/UA80968C2/en
Priority to EA200401301A priority patent/EA008537B1/en
Priority to HU0500201A priority patent/HUP0500201A2/en
Priority to AT03712185T priority patent/ATE374773T1/en
Priority to TW092107597A priority patent/TW200400028A/en
Priority to CNB038084716A priority patent/CN100372845C/en
Priority to IL16420303A priority patent/IL164203A0/en
Priority to MXPA04009601A priority patent/MXPA04009601A/en
Priority to PCT/FI2003/000255 priority patent/WO2003082866A1/en
Priority to BR0309028-0A priority patent/BR0309028A/en
Priority to PL03372657A priority patent/PL372657A1/en
Priority to YU87204A priority patent/RS87204A/en
Priority to AU2003216760A priority patent/AU2003216760A1/en
Priority to NZ535950A priority patent/NZ535950A/en
Priority to KR10-2004-7015702A priority patent/KR20040111473A/en
Priority to JP2003580331A priority patent/JP2005522468A/en
Priority to CA002480695A priority patent/CA2480695A1/en
Priority to DE60316672T priority patent/DE60316672T2/en
Priority to US10/510,019 priority patent/US7592350B2/en
Priority to EP03712185A priority patent/EP1490361B1/en
Priority to ZA200407913A priority patent/ZA200407913B/en
Priority to IS7482A priority patent/IS7482A/en
Priority to NO20044627A priority patent/NO20044627L/en
Priority to HR20041026A priority patent/HRP20041026A2/en
Priority to HK05107766A priority patent/HK1075660A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
FI20020642A 2002-04-03 2002-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists FI20020642A0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
FI20020642A FI20020642A0 (en) 2002-04-03 2002-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
UA20041108959A UA80968C2 (en) 2002-04-03 2003-03-04 Polycyclic compounds as potent alpha-2 adrenoceptor antagonists
EP03712185A EP1490361B1 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
YU87204A RS87204A (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
AU2003216760A AU2003216760A1 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
AT03712185T ATE374773T1 (en) 2002-04-03 2003-04-03 POLYCYCLIC COMPOUNDS AS POTENT ALPHA2-ADRENOCEPTOR ANTAGONISTS
TW092107597A TW200400028A (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
CNB038084716A CN100372845C (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
IL16420303A IL164203A0 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpah2-adrenoceptorantagonists
MXPA04009601A MXPA04009601A (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists.
PCT/FI2003/000255 WO2003082866A1 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
BR0309028-0A BR0309028A (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
PL03372657A PL372657A1 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
EA200401301A EA008537B1 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha-2-adrenoceptor antagonists
HU0500201A HUP0500201A2 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists and pharmaceutical compositions thereof
NZ535950A NZ535950A (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
KR10-2004-7015702A KR20040111473A (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
JP2003580331A JP2005522468A (en) 2002-04-03 2003-04-03 Polycyclic compounds as antagonists of potent α2-adrenergic receptors
CA002480695A CA2480695A1 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
DE60316672T DE60316672T2 (en) 2002-04-03 2003-04-03 POLYCYCLIC COMPOUNDS AS POTENTIAL ALPHA2 ADRENOCEPTOR ANTAGONISTS
US10/510,019 US7592350B2 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
ZA200407913A ZA200407913B (en) 2002-04-03 2004-09-30 Polycyclic compounds as potent alpha2-adrenoceptorantagonists.
IS7482A IS7482A (en) 2002-04-03 2004-10-01 Multicyclic compounds as strong alpha2-adrenoceptor antagonists
NO20044627A NO20044627L (en) 2002-04-03 2004-10-27 Polycyclic compounds as strong alpha2-adrenoceptor antagonists
HR20041026A HRP20041026A2 (en) 2002-04-03 2004-11-02 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
HK05107766A HK1075660A1 (en) 2002-04-03 2005-09-05 Polycyclic compounds as potent alpha2-adrenoceptorantagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20020642A FI20020642A0 (en) 2002-04-03 2002-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists

Publications (1)

Publication Number Publication Date
FI20020642A0 true FI20020642A0 (en) 2002-04-03

Family

ID=8563695

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20020642A FI20020642A0 (en) 2002-04-03 2002-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists

Country Status (6)

Country Link
KR (1) KR20040111473A (en)
FI (1) FI20020642A0 (en)
NO (1) NO20044627L (en)
TW (1) TW200400028A (en)
UA (1) UA80968C2 (en)
ZA (1) ZA200407913B (en)

Also Published As

Publication number Publication date
TW200400028A (en) 2004-01-01
UA80968C2 (en) 2007-11-26
KR20040111473A (en) 2004-12-31
NO20044627L (en) 2004-10-27
ZA200407913B (en) 2005-10-06

Similar Documents

Publication Publication Date Title
DK1562595T3 (en) Diarylethers as opioid receptor antagonists
IS8501A (en) Azate cyclic heterocycles as cannabinonide receptor antagonists
SE0302305D0 (en) Novel Compounds
DE60335915D1 (en) MYOSTATIN-INHIBITING COMPOUNDS
DK1605897T3 (en) POLYETHELEN-GLYCOL-LINK-GLP-1 compounds
IS8108A (en) New compounds
ATE368042T1 (en) CEPHEMEM COMPOUNDS
IS8228A (en) New acetidine compounds
IS7827A (en) New compounds
IS7381A (en) compounds
IS7414A (en) Oxo-azabicyclic compounds
IS8292A (en) New compounds
DE602004004278D1 (en) 4-CYCLOALKYLAMINOPYRAZOLOPYRIMIDINE AS NMDA / NR2B ANTAGONISTS
DK1648882T3 (en) 3-fluoro-piperidines as NMDA / NR2B antagonists
NO20045659L (en) compounds
IS8278A (en) Cycopropyl derivatives as NK3 receptor antagonists
DE60210058D1 (en) ALKOXYCARBONYLAMINO-HETEROARYL CARBOXYLENE DERIVATIVES AS IP ANTAGONISTS
DE50206910D1 (en) SUBSTITUTED Y-LACTON COMPOUNDS AS NMDA ANTAGONISTS
DK1261588T3 (en) Imidazole compounds as alpha2-adrenoceptor antagonists
FI20020642A0 (en) Polycyclic compounds as potent alpha2-adrenoceptor antagonists
SE0303452D0 (en) New compounds
FI20020643A0 (en) Polycyclic compounds as potent alpha2 adrenoceptor antagonists
SE0203348D0 (en) Novel compounds
SE0203722D0 (en) Tetracyclic Immunomodulatory Compounds
SE0200118D0 (en) Novel compounds